MATERIALS AND METHODS 117 118

Minimum inhibitory concentration (MIC) of soluble SESB2V. MIC was performed in 119
Muller-Hinton Broth (MHB) using broth macro-dilution method following CLSI 120 guidelines (30). SESB2V peptide was dissolved in water to make 1000µg/mL stock 121 (cefazoline 330 mg/ml, 100 μl and gentamycin 40 mg/ml, 100 μl). The latter group of 192 rabbits (n=6) were sacrificed after treatment with antibiotics continuously for two days. 193
For corneas with Ti-AMP implants (n=15), rabbits were also divided into 2 groups. One 194 group of rabbits were followed up till Day 2 after bacteria inoculation (n=6 for S. aureus 195 and n=3 for P. aeruginosa) and another group of rabbits (n=3 for S. aureus and n=3 for P. 196 aeruginosa) were followed up till Day 7 post-inoculation. The study design is pictured in 197 were dead (stained red). Quantitative live/dead ratio of bacteria was calculated to 272 compare the antimicrobial properties of the pristine Ti and Ti-AMP substrates (Fig. 2B) . 273
The mean live/dead ratio of S. aureus and P. aeruginosa on pristine Ti substrates (15.8: 1, 274 for S. aureus and 1.66:1 for P. aeruginosa respectively) were significantly higher than 275 those on Ti-AMP substrates (2. (Fig. 3A) . For corneas with the P. aeruginosa inoculation, inflammatory and 295 infection signs occurred in corneas with both pristine Ti (n=6/6) and AMP coated Ti 296 (n=4/6) on Day 1 post-inoculation and worsened on Day 2 post-inoculation (n=6/6 for 297 pristine Ti group and n=4/6 for Ti-AMP group). However, for corneas with Ti-AMP 298 implants, the infection was localized to the central area of the cornea and not as extensive 299 compared with the pristine Ti implants. On Day 7 post-inoculation, there were still signs 300 of localized inflammation and infection in the Ti-AMP group (n=2/3, Supple. Fig. 2A) . 301
Due to the severe melting of cornea, rabbits with pristine Ti implantation group were 302 sacrificed at day 2 post-inoculation hence there was no data collected at day 7 from this 303 group. 304 305 Table 1 2 CFU per cornea in Ti-AMP group (Fig. 4) . 345 346 Tissue sections were analyzed to further evaluate the inflammatory response 347 following bacterial inoculation. At 48 hours post-inoculation, H&E staining of S. aureus 348 infected corneas with pristine Ti implant revealed loss of corneal integrity as a result of 349 "melting" of the epithelial layer in the central cornea (Fig. 5B ). Blood vessels grew into 350 the cornea stroma (Fig. 5C ) and inflammatory cells infiltrated into the central cornea 351 surrounding the area of the implant pocket (Fig. 5C) . However, S. aureus infected 352 corneas with Ti-AMP implant revealed very mild cellular infiltration ( Fig. 5E and F) and 353 the keratocyte nuclei were aligned as in normal cornea (Fig. 5G) . treatment, the signs improved with an average score of 2.67 ± 0.33 (Fig. 7A) . For corneas 365 with antibiotics treatment, the number of S. aureus organisms increased from the initial 366 inoculums of 1000 CFU to 8.3×10
4 CFU per cornea (Fig. 7B ) which was significantly 367 higher (p=0.02) than Ti-AMP group at post inoculation day 2 (6.6×10 3 CFU per cornea). 368
For corneas with P. aeruginosa inoculation and antibiotics treatment, the rabbit corneas 369 developed mild clinical signs of keratitis with an averaged infection score of 1.67 ± 0.33 370 at Day 1 and there were no obvious clinical signs of corneal infection at Day 2 of 371 treatment (Fig. 7C) . No P. aeruginosa organisms were cultivated from the cornea tissue 372 (Fig. 7D) . i t c o r n e a wi t h p r i s t i n e T i i mp l a n t a t i o n a n d b a c t e r i a l i n f e c t i o n . ( B ) Co r n e a l e p i t h e l i u m, ( C) c e n t r a l c o r n e a s t r o ma , ( D) c o r n e a l s t r o ma s u r r o u n d i n g t h e i mp l a n t p o c k e t . E -G: r a b b i t c o r n e a wi t h T i -A MP i mp l a n t a t i o n a n d b a c t e r i a l i n f e c t i o n . ( E ) Co r n e a l e p i t h e l i u m, ( F ) c e n t r a l c o r n e a s t r o ma , ( G) c o r n e a l s t r o ma s u r r o u n d i n g t h e i mp l a n t p o c k e t ( F ) c e n t r a l c o r n e a s t r o ma , ( G) c o r n e a l s t r o ma s u r r o u n d i n g t h e i mp l a n t F i g u r e 6 . I mmu n o s t a i n i n g p i c t u r e s o f r a b b i t c o r n e a a f t e r i n f e c t i o n wi t h S . a u r e u s . Gr e e n , i n f l a mma t o r y c e l l ma r k e r s ; B l u e , DA P I c e l l n u c l e u s c o u n t e r s t a i n i n g . A -C: CD1 1 b s t a i n i n g . ( A ) n o r ma l r a b b i t c o r n e a , ( B ) c o r n e a wi t h p r i s t i n e T i i mp l a n t , ( C) c o r n e a wi t h T i -A MP i mp l a n t . D-F : F 4 / 8 0 s t a i n i n g . ( D) n o r ma l r a b b i t c o r n e a , ( E ) c o r n e a wi t h p r i s t i n e T i i mp l a n t , ( F ) c o r n e a wi t h T i -A MP i mp l a n t . G-I : MMP 9 s t a i n i n g . ( G) n o r ma l r a b b i t c o r n e a , ( H) c o r n e a wi t h p r i s t i n e T i i mp l a n t , ( I ) c o r n e a G-I : MMP 9 s t a i n i n g . ( G) n o r ma l r a b b i t c o r n e a , ( H) c o r n e a wi t h p r i s t i n e T i i mp l a n t , ( I ) c o r n e a wi t h T i -A MP i mp l a n t . 
